Past Meetings

The Inaugural Meeting of the forum provided an overview of AL amyloidosis, and addressed the challenges in clinical trial design for such a complex, multi-systemic disease in a heterogenous population. The meeting established the priorities for future forums.

In this series of meetings addressing one of the priority areas identified at the inaugural meeting, the Amyloidosis Forum focuses on Novel Endpoints and Analyses for Clinical Trials in AL amyloidosis.